Raymond Cross, MD, on JAK Inhibitors in IBD

Dr Cross recaps his presentation on the efficacy and safety of Janus kinase inhibitors in the treatment of both ulcerative colitis and Crohn's disease, presented at the recent AIBD regional meeting in Nashville.